Pharmaceutical preparation to be used as adjuvant treatment of the seborrheic dermatitis even in HIV positive subjects

摘要

A pharmaceutical product to be used as adjuvant treatment of the seborrheic dermatitis even in HIV positive subjects is disclosed, which makes use of methionine, vitamin E and selenium as active principles concurring directly or indirectly in providing a protective response to the damages caused by lipoperoxidation and causing as a consequence together with a diet rich in PUFA-PL (polyunsaturated fatty acids of phospholipids) the skin homeostasis to be restored and the symptomatology of the skin dermatitis to regress.